My Quote Request
No products added yet
6505-01-527-5418
20 Products
NO DOZ
CAFFEINE TABLETS
NSN, MFG P/N
6505015275418
NSN
6505-01-527-5418
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAFFEINE TABLETS 200MG BLISTER PACKED 16TABS
SPECIAL FEATURES: 200MG CAFFEINE TABLET; 16 TABLETS PER BLISTER PACK; INDIVIDULLY SEALED
Related Searches:
NDC00067-2070-16
CAFFEINE TABLETS
NSN, MFG P/N
6505015275418
NSN
6505-01-527-5418
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAFFEINE TABLETS 200MG BLISTER PACKED 16TABS
SPECIAL FEATURES: 200MG CAFFEINE TABLET; 16 TABLETS PER BLISTER PACK; INDIVIDULLY SEALED
Related Searches:
NDC10135-0175-75
CAFFEINE TABLETS
NSN, MFG P/N
6505015275418
NSN
6505-01-527-5418
MFG
MARLEX PHARMACEUTICAL
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAFFEINE TABLETS 200MG BLISTER PACKED 16TABS
SPECIAL FEATURES: 200MG CAFFEINE TABLET; 16 TABLETS PER BLISTER PACK; INDIVIDULLY SEALED
Related Searches:
05-0232
OSELTAMIVIR PHOSPHA
NSN, MFG P/N
6505015280374
NSN
6505-01-528-0374
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OSELTAMIVIR PHOSPHATE CAPSULES 75MG BT 10S
SPECIAL FEATURES: 75 MG OSELTAMIVIR PHOSPHATE, 10S, STORE IN CONTROLLED ROOM TEMPERATURE; USED IN THE TX OF PERSONS AGES OVER 12 YEARS OF AGE WHO ARE DIAGNOSED AS HAVING INFLUENZA TYPE A OR B; NOT A SUBSTITUTE FOR FLU VACCINE; THIS NSN WAS CREATED FOR PANDEMIC STOCKPILE
~1: ONLY. FDA APPROVED LABELING FOR DOD STOCKPILE ONLY
Related Searches:
NDC00004-0800-07
OSELTAMIVIR PHOSPHA
NSN, MFG P/N
6505015280374
NSN
6505-01-528-0374
MFG
ROCHE LABORATORIES INC.
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OSELTAMIVIR PHOSPHATE CAPSULES 75MG BT 10S
SPECIAL FEATURES: 75 MG OSELTAMIVIR PHOSPHATE, 10S, STORE IN CONTROLLED ROOM TEMPERATURE; USED IN THE TX OF PERSONS AGES OVER 12 YEARS OF AGE WHO ARE DIAGNOSED AS HAVING INFLUENZA TYPE A OR B; NOT A SUBSTITUTE FOR FLU VACCINE; THIS NSN WAS CREATED FOR PANDEMIC STOCKPILE
~1: ONLY. FDA APPROVED LABELING FOR DOD STOCKPILE ONLY
Related Searches:
TAMIFLU
OSELTAMIVIR PHOSPHA
NSN, MFG P/N
6505015280374
NSN
6505-01-528-0374
MFG
ROCHE LABORATORIES INC.
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OSELTAMIVIR PHOSPHATE CAPSULES 75MG BT 10S
SPECIAL FEATURES: 75 MG OSELTAMIVIR PHOSPHATE, 10S, STORE IN CONTROLLED ROOM TEMPERATURE; USED IN THE TX OF PERSONS AGES OVER 12 YEARS OF AGE WHO ARE DIAGNOSED AS HAVING INFLUENZA TYPE A OR B; NOT A SUBSTITUTE FOR FLU VACCINE; THIS NSN WAS CREATED FOR PANDEMIC STOCKPILE
~1: ONLY. FDA APPROVED LABELING FOR DOD STOCKPILE ONLY
Related Searches:
05-0219
PENICILLIN V POTASSIUM TABLETS,USP
NSN, MFG P/N
6505015282368
NSN
6505-01-528-2368
05-0219
PENICILLIN V POTASSIUM TABLETS,USP
NSN, MFG P/N
6505015282368
NSN
6505-01-528-2368
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081216
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENICILLIN V POTASSIUM 500MG TABS 40S
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 500 MG PENICILLIN V POTASSIUM TABLETS; 40 TABS PER BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC57866-3614-01
PENICILLIN V POTASSIUM TABLETS,USP
NSN, MFG P/N
6505015282368
NSN
6505-01-528-2368
NDC57866-3614-01
PENICILLIN V POTASSIUM TABLETS,USP
NSN, MFG P/N
6505015282368
NSN
6505-01-528-2368
MFG
VIBRANTA INC.
Description
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081216
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENICILLIN V POTASSIUM 500MG TABS 40S
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 500 MG PENICILLIN V POTASSIUM TABLETS; 40 TABS PER BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
05-0320
INFLUENZA VIRUS VACCINE,USP
NSN, MFG P/N
6505015283757
NSN
6505-01-528-3757
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INFLUENZA VIRUS VACCINE USP SPLIT TRIVALENT 0.5ML DOSE SYRINGE-UNIT VIAL 10S
IMMEDIATE CONTAINER QUANTITY: 10
IMMEDIATE CONTAINER TYPE: SYRINGE UNIT
SPECIAL FEATURES: SPLIT VIRUS; PRESERVATIVE-FREE, 0.5 ML DOSE SYRINGE UNIT; FOR IMMUNIZING PERSONS 6 MONTHS OF AGE AND OLDER;FOR 2005-2006 FLU SEASON FOR VIRUS STRAIN A/NEW CALEDONIA/20/19999 (H1N1-LIKEA/CALIFORNIA/07/2004 (H3N2)-LIKEB/SHANGHAI/361/2002-LIKE; PG OF 10
VALENCE: TRIVALENT
Related Searches:
FLU VACCINE 2005-2006
INFLUENZA VIRUS VACCINE,USP
NSN, MFG P/N
6505015283757
NSN
6505-01-528-3757
FLU VACCINE 2005-2006
INFLUENZA VIRUS VACCINE,USP
NSN, MFG P/N
6505015283757
NSN
6505-01-528-3757
MFG
SANOFI PASTEUR INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INFLUENZA VIRUS VACCINE USP SPLIT TRIVALENT 0.5ML DOSE SYRINGE-UNIT VIAL 10S
IMMEDIATE CONTAINER QUANTITY: 10
IMMEDIATE CONTAINER TYPE: SYRINGE UNIT
SPECIAL FEATURES: SPLIT VIRUS; PRESERVATIVE-FREE, 0.5 ML DOSE SYRINGE UNIT; FOR IMMUNIZING PERSONS 6 MONTHS OF AGE AND OLDER;FOR 2005-2006 FLU SEASON FOR VIRUS STRAIN A/NEW CALEDONIA/20/19999 (H1N1-LIKEA/CALIFORNIA/07/2004 (H3N2)-LIKEB/SHANGHAI/361/2002-LIKE; PG OF 10
VALENCE: TRIVALENT
Related Searches:
NDC49281-0005-50
INFLUENZA VIRUS VACCINE,USP
NSN, MFG P/N
6505015283757
NSN
6505-01-528-3757
NDC49281-0005-50
INFLUENZA VIRUS VACCINE,USP
NSN, MFG P/N
6505015283757
NSN
6505-01-528-3757
MFG
SANOFI PASTEUR INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INFLUENZA VIRUS VACCINE USP SPLIT TRIVALENT 0.5ML DOSE SYRINGE-UNIT VIAL 10S
IMMEDIATE CONTAINER QUANTITY: 10
IMMEDIATE CONTAINER TYPE: SYRINGE UNIT
SPECIAL FEATURES: SPLIT VIRUS; PRESERVATIVE-FREE, 0.5 ML DOSE SYRINGE UNIT; FOR IMMUNIZING PERSONS 6 MONTHS OF AGE AND OLDER;FOR 2005-2006 FLU SEASON FOR VIRUS STRAIN A/NEW CALEDONIA/20/19999 (H1N1-LIKEA/CALIFORNIA/07/2004 (H3N2)-LIKEB/SHANGHAI/361/2002-LIKE; PG OF 10
VALENCE: TRIVALENT
Related Searches:
NDC61314-0656-25
CIPROFLOXACIN OPTHALMIC SOLUTION, USP
NSN, MFG P/N
6505015284028
NSN
6505-01-528-4028
NDC61314-0656-25
CIPROFLOXACIN OPTHALMIC SOLUTION, USP
NSN, MFG P/N
6505015284028
NSN
6505-01-528-4028
MFG
ALCON LABORATORIES INC .
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXACIN OPHTHALMIC SOLUTION USP .3% 2.5 ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 2.500 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 0.3%, 2.5 ML BOTTLE
Related Searches:
NDC10019-0027-04
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505015284033
NSN
6505-01-528-4033
NDC10019-0027-04
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505015284033
NSN
6505-01-528-4033
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS MIDAZOLAM EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
FEATURES PROVIDED: STERILE
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE IV
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MIDAZOLAM HYCDROCHLORIDE INJECTION 5MG PER ML 2 ML SINGLE DOSE VIAL 25S
III PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
05-0249
MESALAMINE DELAYED-
NSN, MFG P/N
6505015285155
NSN
6505-01-528-5155
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 563600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MESALAMINE DELAYED-RELEASED ASACOL TABS 400MG 180S
III SUPPLEMENTARY FEATURES: ANTI-INFLAMMATORY
SPECIAL FEATURES: 400MG MESALAMINE; 180 TABLETS PER BOTTLE; DELAYED RELEASED; STORE AT CONTROLLED ROOM TEMPERATURE, 20-25 DEG. C
Related Searches:
ASACOL
MESALAMINE DELAYED-
NSN, MFG P/N
6505015285155
NSN
6505-01-528-5155
MFG
PROCTER & GAMBLE PHARMACEUTICALS INC.
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 563600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MESALAMINE DELAYED-RELEASED ASACOL TABS 400MG 180S
III SUPPLEMENTARY FEATURES: ANTI-INFLAMMATORY
SPECIAL FEATURES: 400MG MESALAMINE; 180 TABLETS PER BOTTLE; DELAYED RELEASED; STORE AT CONTROLLED ROOM TEMPERATURE, 20-25 DEG. C
Related Searches:
NDC00149-0752-15
MESALAMINE DELAYED-
NSN, MFG P/N
6505015285155
NSN
6505-01-528-5155
MFG
PROCTER & GAMBLE PHARMACEUTICALS INC.
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 563600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MESALAMINE DELAYED-RELEASED ASACOL TABS 400MG 180S
III SUPPLEMENTARY FEATURES: ANTI-INFLAMMATORY
SPECIAL FEATURES: 400MG MESALAMINE; 180 TABLETS PER BOTTLE; DELAYED RELEASED; STORE AT CONTROLLED ROOM TEMPERATURE, 20-25 DEG. C
Related Searches:
05-0218
FLUOCINONIDE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505015285946
NSN
6505-01-528-5946
05-0218
FLUOCINONIDE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505015285946
NSN
6505-01-528-5946
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.050 PERCENTAGE W/V FLUOCINONIDE ACTIVE INGREDIENT
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 840600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLOUCINONIDE TOPICAL SOLUSION, USP, 60ML
III SUPPLEMENTARY FEATURES: STORE AT CONTROLLED ROOM TEMP BETWEEN 20 AND 25 DEG C; AVOID EXCESSIVE HEAT ABOVE 40 DEG C
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: TOPICAL CORTICOSTEROID; IN PLASTIC SQUEEZE BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00093-0266-39
FLUOCINONIDE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505015285946
NSN
6505-01-528-5946
NDC00093-0266-39
FLUOCINONIDE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505015285946
NSN
6505-01-528-5946
MFG
TEVA PHARMACEUTICALS USA INC. DBA GATE PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.050 PERCENTAGE W/V FLUOCINONIDE ACTIVE INGREDIENT
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 840600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLOUCINONIDE TOPICAL SOLUSION, USP, 60ML
III SUPPLEMENTARY FEATURES: STORE AT CONTROLLED ROOM TEMP BETWEEN 20 AND 25 DEG C; AVOID EXCESSIVE HEAT ABOVE 40 DEG C
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: TOPICAL CORTICOSTEROID; IN PLASTIC SQUEEZE BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC51672-1273-04
FLUOCINONIDE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505015285946
NSN
6505-01-528-5946
NDC51672-1273-04
FLUOCINONIDE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505015285946
NSN
6505-01-528-5946
MFG
TARO PHARMACEUTICALS USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.050 PERCENTAGE W/V FLUOCINONIDE ACTIVE INGREDIENT
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 840600
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLOUCINONIDE TOPICAL SOLUSION, USP, 60ML
III SUPPLEMENTARY FEATURES: STORE AT CONTROLLED ROOM TEMP BETWEEN 20 AND 25 DEG C; AVOID EXCESSIVE HEAT ABOVE 40 DEG C
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: TOPICAL CORTICOSTEROID; IN PLASTIC SQUEEZE BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
05-0145
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505015286335
NSN
6505-01-528-6335
05-0145
CEFTAZIDIME FOR INJECTION,USP
NSN, MFG P/N
6505015286335
NSN
6505-01-528-6335
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081206
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME F/INJ 1GM ADD-VANTAGE VI TRAY OF 25S
III SUPPLEMENTARY FEATURES: ADD-VANTAGE VIALS TO BE USED BY ABBOTT ADD-VANTAGE DILUENT CONTAINERS ONLY
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: STORE IN A DRY STATE, BETWEEN 15 AND 30 DEG. C; PROTECT FROM LIGHT; TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; TRAY OF 25S
TOTAL PRIMARY CONTAINER QUANTITY: 25
